Wasserman S I, Austen K F
J Clin Invest. 1976 Mar;57(3):738-44. doi: 10.1172/JCI108332.
Arylsulfatase B was separated from arylsulfatase A in extracts of human lung tissue by anion exchange chromatography and further purified by gel filtration and cation exchange chromatography. Arylsulfatase B of human lung was similar to that enzyme in other tissues and species, exhibiting an apparent mol wt of approximately 60,000, a pH optimum for cleavage of 4-nitrocatechol sulfate (pNCS) of 5.5-6.0, and a sensitivity to inhibition by phosphate ions and especially pyrophosphate in the presence of NaCl. Human lung arylsulfatase B inactivated slow-reacting substance of anaphylaxix (SRS-A) in a linear time-dependent reaction in which the rate was determined by the enzyme-to-substrate ratio. Cleavage of pNCS by human lung arylsulfatase B was competitively suppressed by SRS-A. The finding that human lung tissue contains predominately arylsulfatase B discloses a potential regulatory mechanism for inactivation of SRS-A at or near the site of its generation.
通过阴离子交换色谱法从人肺组织提取物中分离出芳基硫酸酯酶B,并通过凝胶过滤和阳离子交换色谱法进一步纯化。人肺中的芳基硫酸酯酶B与其他组织和物种中的该酶相似,其表观分子量约为60,000,裂解4-硝基邻苯二酚硫酸盐(pNCS)的最适pH为5.5 - 6.0,在NaCl存在下对磷酸根离子尤其是焦磷酸根离子的抑制敏感。人肺芳基硫酸酯酶B在一个线性时间依赖性反应中使过敏反应慢反应物质(SRS-A)失活,该反应的速率由酶与底物的比例决定。SRS-A竞争性抑制人肺芳基硫酸酯酶B对pNCS的裂解。人肺组织主要含有芳基硫酸酯酶B这一发现揭示了在SRS-A产生部位或其附近使其失活的潜在调节机制。